Ajuts a la recerca

Grants 4Targets: To Novel Drugs:Oncology, Gynecology, Cardiology or Hematology

Organisme

Bayer company’s mission is to provide new treatment options for diseases with high unmet medical need.

Objecte

We are committed to innovation and to translating ideas from basic research into novel drugs. We are dedicated to fostering collaborations with excellent academic groups and start-ups. We strive for pooling expertise on common research topics and joining forces for mutual benefit.

To foster the translation of ideas into innovation we are looking for novel drug targets as a basis for the development of new therapeutic approaches. In addition, we are also interested in disease-related biomarkers in the therapeutic fields mentioned below. To foster the translation of ideas into innovation we are looking for novel drug targets as a basis for the development of new therapeutic approaches. In addition, we are also interested in disease-related biomarkers in the therapeutic fields mentioned below. Diseases: The call is focused in novel targets and disease-related biomarkers in the fields of:

1. Oncology: Focus on anti-proliferative, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, immunotherapy and antibody-drug conjugates.

2. Gynecology: Focus on novel treatment options for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leimyoma).

3. Cardiology: Focus on novel approaches to the care of chronic and/or acute pulmonary hypertension & adjacent lung indications, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occusive disease, acute lung injury / adult respiratory distress syndrome, cardiorenal syndrome and chronic kidney diseases.

4. Hematology: Focus on hemophelia, anemia and thrombocytiopenia.
 

Termini oficial

The annual submission deadlines are March 31 and August 31.

Termini IISPV

Declaration of interest: IISPV's deadline: 07/14/2014 (europa@iispv.cat) IISPV's deadline LOI: August 25th, 2014

Pujar